Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Anti-Coagulant Blockbuster Drugs Are Here
Seeking Alpha
Mon, 07/25/11 - 09:08 am
Tags:
anticlotting, blood thinners, JNJ, Pfizer, AstraZeneca, Bristol-Myers Squibb, Bayer, Xarelto, Pradaxa, Boehringer Ingelheim, Eliquis
Boehringer Must Pay Overtime To Sales Rep: Judge
Pharmalot
Thu, 07/14/11 - 01:05 pm
Tags:
overtime lawsuits, Boehringer Ingelheim, drug reps
Two-Year Data Comparing Cardiovascular Events with Linagliptin and the Sulfonylurea, Glimepiride, Presented as Late-Breaking Poster at ADA
Yahoo/PR NewsWire
Sat, 06/25/11 - 08:42 pm
Tags:
linagliptin, sulfonylurea, glimepiride, diabetes, Boehringer Ingelheim, Eli Lilly
New Phase III Data and Pooled Analysis for Linagliptin Show Improved Blood Sugar Control in Adults With Type 2 Diabetes When Used Alone and With Metformin
Yahoo/PR NewsWire
Sat, 06/25/11 - 12:03 pm
Tags:
linagliptin, Boehringer Ingelheim, Eli Lilly, diabetes
Analysis: Data may help Bristol/Pfizer clot drug catch rivals
CNBC
Fri, 06/17/11 - 09:42 am
Tags:
Pfizer, blood thinners, Bristol-Myers Squibb, Apixaban, Boehringer Ingelheim, Pradaxa, JNJ, Xarelto, Bayer
Boehringer Ingelheim and Lilly's New Type 2 Diabetes Treatment Tradjenta (Linagliptin) Tablets for Adults Now Available in U.S. Pharmacies
Pharma Live
Thu, 06/16/11 - 11:25 am
Tags:
Eli Lilly, Boehringer Ingelheim, type 2 diabetes, Tradjenta
Is Boehringer Providing Proper Informed Consent?
Pharmalot
Wed, 06/15/11 - 12:55 pm
Tags:
COPD, Spiriva, Boehringer Ingelheim, Pfizer
Boehringer, Pfizer’s Spiriva May Raise Death Risk, Study Finds
Bloomberg
Tue, 06/14/11 - 08:04 pm
Tags:
Pfizer, Boehringer Ingelheim, Spiriva, COPD
Why A Boehringer Unit Really Has Drug Shortages
Pharmalot
Mon, 06/13/11 - 09:19 am
Tags:
drug shortages, Boehringer Ingelheim
Federal court issues restraining order against Eli Lilly in federal lawsuit filed by Amylin
Yahoo/AP
Thu, 05/26/11 - 11:21 am
Tags:
Eli Lilly, Amylin, restraining order, Byetta, Boehringer Ingelheim, linagliptin, drug reps
Amylin Pharma sues Eli Lilly over diabetes drug development deal with Boehringer Ingelheim
Yahoo/AP
Mon, 05/16/11 - 09:32 am
Tags:
Amylin, lawsuits, Eli Lilly, Boehringer Ingelheim, diabetes, Byetta
Lilly, Boehringer Win FDA Approval for Type 2 Diabetes Drug
Bloomberg
Mon, 05/2/11 - 07:21 pm
Tags:
Eli Lilly, FDA, diabetes, type 2 diabetes, Boehringer Ingelheim, linagliptin
Boehringer’s Pradaxa Blood-Thinner Beats Bayer to EU Opinion
Bloomberg
Fri, 04/15/11 - 11:19 am
Tags:
Boehringer Ingelheim, Pradaxa, blood thinners, Bayer, Europe
BioSante's Potential Blockbuster Treatment
Seeking Alpha
Thu, 03/31/11 - 12:29 pm
Tags:
BioSante, LibiGel, female sexual dysfunction, Boehringer Ingelheim, Warner Chilcott
Boehringer, Pfizer’s Spiriva Bests Glaxo Drug for Lung Disorder
Bloomberg
Thu, 03/24/11 - 09:33 am
Tags:
Boehringer Ingelheim, Pfizer, Spiriva, GSK, COPD, Serevent
Boehringer Blood Thinner Added to Heart Guidelines
Bloomberg
Mon, 02/14/11 - 05:52 pm
Tags:
Boehringer Ingelheim, blood thinners, Pradaxa
Bids Due for Sanofi, Merck Animal Health Assets, FTD Reports
Bloomberg
Wed, 01/19/11 - 10:38 am
Tags:
animal health, Merck, Sanofi, Novartis, Bayer, Boehringer Ingelheim
Lilly Beefs Up Diabetes Pipeline With Boehringer Deal
Seeking Alpha
Sun, 01/16/11 - 11:38 am
Tags:
Eli Lilly, Boehringer Ingelheim, diabetes
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:24 pm
Tags:
Watson Pharmaceuticals, Theratechnologies, Shire, Savient, Sanofi, Roche, Orphan Europe, Novo Nordisk, Novartis, Merz, JNJ, HRA Pharma, Genzyme, Forest Labs, FDA, Eisai, Dainippon Sumitomo, Chemiche Fabrik Kresussler, Boehringer Ingelheim, Bayer, Auxilium, Amgen, Allergan, Acorda Therapeutics
Eli Lilly, Boehringer Ingelheim launch collaboration to develop diabetes treatments
Yahoo/AP
Tue, 01/11/11 - 12:45 pm
Tags:
Eli Lilly, Boehringer Ingelheim, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.